Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Ectopic, retroperitoneal adrenocortical carcinoma in the setting of Lynch syndrome.

Wright JP, Montgomery KW, Tierney J, Gilbert J, Solórzano CC, Idrees K.

Fam Cancer. 2018 Jul;17(3):381-385. doi: 10.1007/s10689-017-0042-6.

PMID:
28940135
2.

Familial Adrenocortical Carcinoma in Association With Lynch Syndrome.

Challis BG, Kandasamy N, Powlson AS, Koulouri O, Annamalai AK, Happerfield L, Marker AJ, Arends MJ, Nik-Zainal S, Gurnell M.

J Clin Endocrinol Metab. 2016 Jun;101(6):2269-72. doi: 10.1210/jc.2016-1460. Epub 2016 May 4.

3.

Adrenocortical carcinoma, an unusual extracolonic tumor associated with Lynch II syndrome.

Medina-Arana V, Delgado L, González L, Bravo A, Díaz H, Salido E, Riverol D, González-Aguilera JJ, Fernández-Peralta AM.

Fam Cancer. 2011 Jun;10(2):265-71. doi: 10.1007/s10689-010-9416-8.

PMID:
21225464
4.

Adrenocortical carcinoma is a lynch syndrome-associated cancer.

Raymond VM, Everett JN, Furtado LV, Gustafson SL, Jungbluth CR, Gruber SB, Hammer GD, Stoffel EM, Greenson JK, Giordano TJ, Else T.

J Clin Oncol. 2013 Aug 20;31(24):3012-8. doi: 10.1200/JCO.2012.48.0988. Epub 2013 Jul 22. Erratum in: J Clin Oncol. 2013 Oct 1;31(28):3612.

5.

Development of new preclinical models to advance adrenocortical carcinoma research.

Kiseljak-Vassiliades K, Zhang Y, Bagby SM, Kar A, Pozdeyev N, Xu M, Gowan K, Sharma V, Raeburn CD, Albuja-Cruz M, Jones KL, Fishbein L, Schweppe RE, Somerset H, Pitts TM, Leong S, Wierman ME.

Endocr Relat Cancer. 2018 Apr;25(4):437-451. doi: 10.1530/ERC-17-0447. Epub 2018 Jan 25.

6.

Upper tract urothelial carcinomas: frequency of association with mismatch repair protein loss and lynch syndrome.

Harper HL, McKenney JK, Heald B, Stephenson A, Campbell SC, Plesec T, Magi-Galluzzi C.

Mod Pathol. 2017 Jan;30(1):146-156. doi: 10.1038/modpathol.2016.171. Epub 2016 Oct 7.

7.

Malignant fibrous histiocytoma is a rare Lynch syndrome-associated tumor in two German families.

Brieger A, Engels K, Schaefer D, Plotz G, Zeuzem S, Raedle J, Trojan J.

Fam Cancer. 2011 Sep;10(3):591-5. doi: 10.1007/s10689-011-9455-9.

PMID:
21598002
8.

Germline mutation analysis of MLH1 and MSH2 in Malaysian Lynch syndrome patients.

Zahary MN, Kaur G, Abu Hassan MR, Singh H, Naik VR, Ankathil R.

World J Gastroenterol. 2012 Feb 28;18(8):814-20. doi: 10.3748/wjg.v18.i8.814.

9.

Pancreatic intraductal papillary mucinous neoplasm in a patient with Lynch syndrome.

Flanagan MR, Jayaraj A, Xiong W, Yeh MM, Raskind WH, Pillarisetty VG.

World J Gastroenterol. 2015 Mar 7;21(9):2820-5. doi: 10.3748/wjg.v21.i9.2820.

10.

Unusual DNA mismatch repair-deficient tumors in Lynch syndrome: a report of new cases and review of the literature.

Karamurzin Y, Zeng Z, Stadler ZK, Zhang L, Ouansafi I, Al-Ahmadie HA, Sempoux C, Saltz LB, Soslow RA, O'Reilly EM, Paty PB, Coit DG, Shia J, Klimstra DS.

Hum Pathol. 2012 Oct;43(10):1677-87. doi: 10.1016/j.humpath.2011.12.012. Epub 2012 Apr 17. Review.

PMID:
22516243
11.

Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome.

Gargiulo S, Torrini M, Ollila S, Nasti S, Pastorino L, Cusano R, Bonelli L, Battistuzzi L, Mastracci L, Bruno W, Savarino V, Sciallero S, Borgonovo G, Nyström M, Bianchi-Scarrà G, Mareni C, Ghiorzo P.

Fam Cancer. 2009;8(4):547-53. doi: 10.1007/s10689-009-9285-1.

PMID:
19728162
12.

Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers.

van der Post RS, Kiemeney LA, Ligtenberg MJ, Witjes JA, Hulsbergen-van de Kaa CA, Bodmer D, Schaap L, Kets CM, van Krieken JH, Hoogerbrugge N.

J Med Genet. 2010 Jul;47(7):464-70. doi: 10.1136/jmg.2010.076992.

13.

Mismatch repair gene mutation spectrum in the Swedish Lynch syndrome population.

Lagerstedt-Robinson K, Rohlin A, Aravidis C, Melin B, Nordling M, Stenmark-Askmalm M, Lindblom A, Nilbert M.

Oncol Rep. 2016 Nov;36(5):2823-2835. doi: 10.3892/or.2016.5060. Epub 2016 Sep 1.

14.

An Interesting Case of Hepatic Adrenocortical Carcinoma.

Permana H, Darmawan G, Ritonga E, Kusumawati M, Miftahurachman M, Soetedjo NN.

Acta Med Indones. 2018 Jul;50(3):257-259.

15.

Hereditary prostate cancer as a feature of Lynch syndrome.

Bauer CM, Ray AM, Halstead-Nussloch BA, Dekker RG, Raymond VM, Gruber SB, Cooney KA.

Fam Cancer. 2011 Mar;10(1):37-42. doi: 10.1007/s10689-010-9388-8.

16.

Papillary thyroid carcinoma (PTC) in Lynch syndrome: Report of two cases and discussion on Lynch syndrome behaviour and genetics.

Pelizzo MR, Pennelli G, Zane M, Galuppini F, Colletti PM, Merante Boschin I, Rubello D.

Biomed Pharmacother. 2015 Aug;74:9-16. doi: 10.1016/j.biopha.2015.06.008. Epub 2015 Jul 13.

PMID:
26349957
17.

Medullary carcinoma of the pancreas in a man with hereditary nonpolyposis colorectal cancer due to a mutation of the MSH2 mismatch repair gene.

Banville N, Geraghty R, Fox E, Leahy DT, Green A, Keegan D, Geoghegan J, O'Donoghue D, Hyland J, Sheahan K.

Hum Pathol. 2006 Nov;37(11):1498-502. Epub 2006 Sep 25.

PMID:
16996571
18.

Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study.

Kloor M, Huth C, Voigt AY, Benner A, Schirmacher P, von Knebel Doeberitz M, Bläker H.

Lancet Oncol. 2012 Jun;13(6):598-606. doi: 10.1016/S1470-2045(12)70109-2. Epub 2012 May 1.

PMID:
22552011
19.

Muir-Torre Syndrome and founder mismatch repair gene mutations: A long gone historical genetic challenge.

Ponti G, Manfredini M, Tomasi A, Pellacani G.

Gene. 2016 Sep 10;589(2):127-32. doi: 10.1016/j.gene.2015.06.078. Epub 2015 Jul 2. Review.

PMID:
26143115
20.

Screening for germline mutations of MLH1, MSH2, MSH6 and PMS2 genes in Slovenian colorectal cancer patients: implications for a population specific detection strategy of Lynch syndrome.

Berginc G, Bracko M, Ravnik-Glavac M, Glavac D.

Fam Cancer. 2009;8(4):421-9. doi: 10.1007/s10689-009-9258-4. Epub 2009 Jun 13.

PMID:
19526325

Supplemental Content

Support Center